豚ワクチンの世界市場レポート 2025年

豚ワクチンの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で34億4,000万米ドルに成長します。予測期間の成長は、新たな疾病やウイルス株、養豚産業の世界化、気候や環境の変化、バイオセキュリティ対策、市場競争に起因しています。予測期間の主な動向には、獣医学の進歩、進化する疾病パターン、世界のタンパク質需要、技術の進歩、予防ヘルスケアへの注力などがあります。

豚の疾病発生率の増加は、将来的に豚ワクチン市場を牽引すると予測されています。豚の病気とは、生物の正常な構造的または機能的状態からの逸脱を指し、多くの場合、仮性狂犬病やインフルエンザなどの病気の徴候や症状を伴います。豚ワクチンは、免疫系を刺激して特定の病原体を認識・反応させることで、感染率を低下させ、疾病の重症度を緩和し、牛群全体の健康を促進することで、増加するこれらの疾病の蔓延に効果的に対処します。例えば、2023年12月、米国を拠点とする豚健康情報センター（Swine Health Information Center）は、ポーランドの野生のイノシシの間でアフリカ豚熱（ASF）の症例が増加していることを報告しました。2023年初めまでに、同国では野生のイノシシで確認されたASFの症例が2,347件となり、2022年の合計を上回りました。その結果、豚の疾病の流行が増加しており、市場の成長を後押しすると予想されます。

豚肉の世界の消費量の増加は、将来的に豚ワクチン市場の成長に寄与すると予想されます。豚肉消費は、豚から供給される様々な豚肉製品の調理や消費を通じて、個人が豚肉を食生活に取り入れることを含みます。豚ワクチンは、豚の個体群の健康を維持し、疾病発生のリスクを最小限に抑え、安全で高品質な豚肉を世界中で生産するために不可欠です。例えば、2023年3月、イタリアに本部を置く連邦組織である食糧農業機関は、豚肉は世界で消費される食肉の約36％を占め、その総量は112.6キロトンに達し、2031年には129キロトンに増加すると予測していると発表しました。したがって、豚肉消費量の世界の増加が豚ワクチン市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の豚ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の豚ワクチン市場：成長率分析
• 世界の豚ワクチン市場の実績：規模と成長, 2019-2024
• 世界の豚ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界の豚ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の豚ワクチン市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 弱毒生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNA（デオキシリボ核酸）ワクチン
• 組み換えワクチン
• 世界の豚ワクチン市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルス感染
• 細菌感染症
• 寄生虫感染
• 真菌感染症
• その他の疾患
• 世界の豚ワクチン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 動物用薬局
• オンライン薬局
• 世界の豚ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 政府入札
• 市場販売
• 世界の豚ワクチン市場：弱毒生ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化ウイルスワクチン
• 生弱毒細菌ワクチン
• 世界の豚ワクチン市場：不活化ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全不活化ウイルスワクチン
• 不活化細菌ワクチン
• 世界の豚ワクチン市場：サブユニットワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タンパク質サブユニットワクチン
• 多糖サブユニットワクチン
• 世界の豚ワクチン市場：DNA（デオキシリボ核酸）ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プラスミドDNAワクチン
• 核酸ワクチン
• 世界の豚ワクチン市場：組換えワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えベクターワクチン
• 組み換えタンパク質ワクチン

第7章 地域別・国別分析

• 世界の豚ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の豚ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 豚ワクチン市場：競合情勢
• 豚ワクチン市場：企業プロファイル
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
  • Phibro Animal Health Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• KM Biologics Co. Ltd.
• Hipra Laboratories SA
• Ceva Sante Animale SA
• Zoetis Inc.
• Jinyu Bio-Technology Co. Ltd.
• China Animal Husbandry Industry Co. Ltd.
• Virbac SA
• Harbin Veterinary Research Institute
• Bioveta AS
• Bimeda Holdings PLC
• Biovac Ltd.
• Hester Biosciences Limited
• Hygieia Biological Laboratories
• IDT Biologika GmbH
• Intervet Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 豚ワクチン市場2029：新たな機会を提供する国
• 豚ワクチン市場2029：新たな機会を提供するセグメント
• 豚ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A swine vaccine is a formulation given or injected into pigs to provoke an immune response against a particular infectious agent. These vaccines play a vital role in preventing diseases that can adversely affect pig health, productivity, and overall herd management.

The primary types of swine vaccines include attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines consist of weakened living viruses or bacteria that have been altered to reduce their pathogenicity. These vaccines aim to trigger a robust immune response in pigs by replicating within the body, leading to prolonged immunity. They are effective against various diseases including viral, bacterial, parasitic, and fungal infections. Swine vaccines are distributed through veterinary hospitals, veterinary pharmacies, and online pharmacies. These products are available through government tenders and sales in the market.

The swine vaccines market research report is one of a series of new reports from The Business Research Company that provides swine vaccines market statistics, including swine vaccines industry global market size, regional shares, competitors with a swine vaccines market share, detailed swine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the swine vaccines industry. This swine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The swine vaccines market size has grown strongly in recent years. It will grow from $2.18 billion in 2024 to $2.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to disease outbreaks, economic losses, government regulations, increased swine production.

The swine vaccines market size is expected to see strong growth in the next few years. It will grow to $3.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging diseases and viral strains, globalization of swine industry, climate and environmental changes, biosecurity measures, market competition. Major trends in the forecast period include veterinary advancements, evolving disease patterns, global demand for protein, technological advancements, preventive healthcare focus.

The growing incidence of diseases in swine is anticipated to drive the swine vaccine market in the future. Swine disease refers to any deviation from the normal structural or functional condition of an organism, often accompanied by signs and symptoms of ailments such as pseudorabies and influenza. Swine vaccines effectively address the increasing prevalence of these diseases by stimulating the immune system to recognize and respond to specific pathogens, thus reducing infection rates, alleviating disease severity, and promoting overall herd health. For example, in December 2023, the Swine Health Information Center, a US-based organization, reported a concerning rise in cases of African Swine Fever (ASF) among wild boars in Poland. By early 2023, the country had recorded 2,347 confirmed ASF cases in wild boars, surpassing the total from 2022. Consequently, the rising prevalence of diseases in swine is expected to boost market growth.

The rising global consumption of pork is expected to contribute to the growth of the swine vaccine market in the future. Pork consumption involves individuals incorporating pork into their diet through the preparation and consumption of various pork products sourced from pigs. Swine vaccines are essential for maintaining the health of pig populations, minimizing the risk of disease outbreaks, and ensuring the production of safe, high-quality pork worldwide. For instance, in March 2023, the Food and Agriculture Organization, an Italy-based federal organization, stated that pork constituted approximately 36% of the meat consumed globally, totaling 112.6 kilotons, with projections to increase to 129 kilotons by 2031. Therefore, the rising global pork consumption is driving the growth of the swine vaccine market.

Technological innovation is a significant trend gaining traction in the swine vaccine market. Leading companies are focusing on developing advanced technologies that enable the simultaneous delivery of two vaccines to enhance swine health and maintain their market position. For instance, in May 2022, Boehringer Ingelheim, a Germany-based pharmaceutical firm, introduced TwistPak technology. TwistPak is a groundbreaking platform that combines two vaccines, IngelvacCircoFLEX and IngelvacMycoFLEX, specifically for swine producers. This technology provides a convenient and time-efficient solution, facilitating a simplified mixing process while allowing flexibility to use the products either as a combined vaccine or as individual monovalent options. It is produced using advanced technologies and features an ergonomic design.

Prominent companies in the swine vaccine market are increasingly prioritizing the introduction of innovative vaccines, such as Circumvent CML, to enhance their competitive advantage. Circumvent CML is a vaccine aimed at safeguarding swine herds against various diseases, thereby improving overall swine health and productivity. For example, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched a new 3-in-one swine vaccine named Circumvent CML, which addresses the diseases caused by Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. This new vaccine is founded on Merck's established, proven antigens and adjuvant systems that have been utilized in Circumvent PCV-M G2 and their standalone product, Porcilis Ileitis.

In July 2024, MSD Animal Health, a US-based biopharmaceutical firm, acquired Elanco's aqua business for $1.3 billion. Through this acquisition, MSD Animal Health aims to substantially strengthen its presence in the aquaculture sector by broadening its range of products and solutions designed to enhance fish health, welfare, and sustainability. Elanco is a US-based pharmaceutical company that specializes in providing vaccine solutions for swine.

Major companies operating in the swine vaccines market are Merck & Co Inc., Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Inc., Biogenesis Bago SA, Phibro Animal Health Corporation, KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Sante Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings PLC, Biovac Ltd., Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Intervet Inc., Komipharm International Co. Ltd., Kyoritsu Seiyaku Corporation, Lohmann Animal Health International, Norbrook Laboratories Limited, Ouro Fino Saude Animal SA, Prondil SA, Vaxxinova International BV, Vetoquinol SA, Veyx Pharma GmbH, Tianjin Ringpu Bio-Technology Co. Ltd.

North America was the largest region in the swine vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the swine vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The swine vaccine market consists of sales of haemophilus parasuis, pasteurella, salmonella, and streptococcus suis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Swine Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on swine vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for swine vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The swine vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Attenuated Live Vaccines; Inactivated Vaccines; Subunit Vaccines; DNA (Deoxyribonucleic Acid) Vaccines; Recombinant Vaccines
• 2) By Disease: Viral Infections; Bacterial Infections; Parasitic Infection; Fungal Infections; Other Diseases
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Pharmacies; Online Pharmacies
• 4) By Application: Government Tender; Market Sales
• Subsegments:
• 1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines; Live Attenuated Bacterial Vaccines
• 2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines; Inactivated Bacterial Vaccines
• 3) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines
• 4) By DNA (Deoxyribonucleic Acid) Vaccines: Plasmid DNA Vaccines; Nucleic Acid Vaccines
• 5) By Recombinant Vaccines: Recombinant Vector Vaccines; Recombinant Protein Vaccines
• Companies Mentioned: Merck & Co Inc.; Boehringer Ingelheim Animal Health USA Inc.; Elanco Animal Health Inc.; Biogenesis Bago SA; Phibro Animal Health Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Swine Vaccines Market Characteristics

3. Swine Vaccines Market Trends And Strategies

4. Swine Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Swine Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Swine Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Swine Vaccines Market Growth Rate Analysis
• 5.4. Global Swine Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Swine Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Swine Vaccines Total Addressable Market (TAM)

6. Swine Vaccines Market Segmentation

• 6.1. Global Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA (Deoxyribonucleic Acid) Vaccines
• Recombinant Vaccines
• 6.2. Global Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Infections
• Bacterial Infections
• Parasitic Infection
• Fungal Infections
• Other Diseases
• 6.3. Global Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Pharmacies
• Online Pharmacies
• 6.4. Global Swine Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government Tender
• Market Sales
• 6.5. Global Swine Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Virus Vaccines
• Live Attenuated Bacterial Vaccines
• 6.6. Global Swine Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Inactivated Virus Vaccines
• Inactivated Bacterial Vaccines
• 6.7. Global Swine Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Subunit Vaccines
• Polysaccharide Subunit Vaccines
• 6.8. Global Swine Vaccines Market, Sub-Segmentation Of DNA (Deoxyribonucleic Acid) Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasmid DNA Vaccines
• Nucleic Acid Vaccines
• 6.9. Global Swine Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Vector Vaccines
• Recombinant Protein Vaccines

7. Swine Vaccines Market Regional And Country Analysis

• 7.1. Global Swine Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Swine Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Swine Vaccines Market

• 8.1. Asia-Pacific Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Swine Vaccines Market

• 9.1. China Swine Vaccines Market Overview
• 9.2. China Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Swine Vaccines Market

• 10.1. India Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Swine Vaccines Market

• 11.1. Japan Swine Vaccines Market Overview
• 11.2. Japan Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Swine Vaccines Market

• 12.1. Australia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Swine Vaccines Market

• 13.1. Indonesia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Swine Vaccines Market

• 14.1. South Korea Swine Vaccines Market Overview
• 14.2. South Korea Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Swine Vaccines Market

• 15.1. Western Europe Swine Vaccines Market Overview
• 15.2. Western Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Swine Vaccines Market

• 16.1. UK Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Swine Vaccines Market

• 17.1. Germany Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Swine Vaccines Market

• 18.1. France Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Swine Vaccines Market

• 19.1. Italy Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Swine Vaccines Market

• 20.1. Spain Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Swine Vaccines Market

• 21.1. Eastern Europe Swine Vaccines Market Overview
• 21.2. Eastern Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Swine Vaccines Market

• 22.1. Russia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Swine Vaccines Market

• 23.1. North America Swine Vaccines Market Overview
• 23.2. North America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Swine Vaccines Market

• 24.1. USA Swine Vaccines Market Overview
• 24.2. USA Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Swine Vaccines Market

• 25.1. Canada Swine Vaccines Market Overview
• 25.2. Canada Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Swine Vaccines Market

• 26.1. South America Swine Vaccines Market Overview
• 26.2. South America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Swine Vaccines Market

• 27.1. Brazil Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Swine Vaccines Market

• 28.1. Middle East Swine Vaccines Market Overview
• 28.2. Middle East Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Swine Vaccines Market

• 29.1. Africa Swine Vaccines Market Overview
• 29.2. Africa Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Swine Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Swine Vaccines Market Competitive Landscape
• 30.2. Swine Vaccines Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Phibro Animal Health Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Swine Vaccines Market Other Major And Innovative Companies

• 31.1. KM Biologics Co. Ltd.
• 31.2. Hipra Laboratories SA
• 31.3. Ceva Sante Animale SA
• 31.4. Zoetis Inc.
• 31.5. Jinyu Bio-Technology Co. Ltd.
• 31.6. China Animal Husbandry Industry Co. Ltd.
• 31.7. Virbac SA
• 31.8. Harbin Veterinary Research Institute
• 31.9. Bioveta AS
• 31.10. Bimeda Holdings PLC
• 31.11. Biovac Ltd.
• 31.12. Hester Biosciences Limited
• 31.13. Hygieia Biological Laboratories
• 31.14. IDT Biologika GmbH
• 31.15. Intervet Inc.

32. Global Swine Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Swine Vaccines Market

34. Recent Developments In The Swine Vaccines Market

35. Swine Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Swine Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Swine Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Swine Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer